TERRY L. LIERMAN - 17 Oct 2025 Form 4 Insider Report for IGC Pharma, Inc. (IGC)

Role
Director
Signature
/s/ Terry L. Lierman
Issuer symbol
IGC
Transactions as of
17 Oct 2025
Net transactions value
$0
Form type
4
Filing time
21 Oct 2025, 08:47:45 UTC
Previous filing
15 Mar 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
LIERMAN TERRY L Director 10224 FALLS ROAD, POTOMAC /s/ Terry L. Lierman 21 Oct 2025 0002014677

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IGC Options Award $0 +500,000 $0.000000 500,000 17 Oct 2025 Common Stock 500,000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted 500,000 options exercisable at $0.35, equally vesting over the next three years starting in March 31st 2026.